Poultry Health Risks: Salmonella, Campylobacter, E. coli, Avian Influenza
The Alabama Department of Public Health issued a notice regarding health risks associated with handling backyard poultry during 'Chick Days'. The notice highlights potential exposure to Salmonella, Campylobacter, E. coli, and avian influenza, referencing 2025 outbreaks that caused illnesses and hospitalizations.
WHO Hub Berlin Highlights 2025 Achievements in Pandemic Intelligence
The WHO Hub for Pandemic and Epidemic Intelligence in Berlin released its 2025 Annual Report, detailing advancements in AI, data science, and genomics for global health threat detection. The report highlights collaboration with over 160 Member States and 190 partners to enhance pandemic preparedness.
HHS OIG: Nursing Homes Misdiagnosed Residents to Mask Antipsychotic Drug Misuse
The HHS Office of Inspector General (OIG) issued a report finding that nursing homes inappropriately diagnosed residents with schizophrenia to mask the misuse of antipsychotic drugs and artificially inflate their star ratings. The OIG recommends that CMS expand its use of data to monitor these diagnoses and increase efforts to inform residents and families about antipsychotic drug use.
HHS OIG: Nursing Homes Misuse Antipsychotics on Dementia Residents
The HHS Office of Inspector General (OIG) issued a report finding that nursing homes inappropriately administer antipsychotic drugs to residents with dementia, often to manage behavior for staff benefit, despite FDA warnings of increased mortality risk. The report recommends CMS develop resources and increase transparency to reduce misuse and improve dementia care.
HHS OIG: Indiana Nursing Homes Generally Complied with Federal Background Check Requirements
The HHS Office of Inspector General (OIG) reported that Indiana nursing homes generally complied with federal requirements for employee background checks. Out of 825 employees reviewed, only 13 lacked completed background checks, and none had disqualifying offenses.
Curosurf Safety Information and Lot Recall
The French drug agency ANSM, in agreement with Laboratoire Chiesi SAS, has initiated a recall of one lot (Lot 1204229, Exp 04/2026) of Curosurf 120 mg/1.5 ml suspension for endotracheobronchial instillation. This precautionary measure follows a deviation observed during environmental monitoring at the production site.
ANSM Security Alert for EdgeSuite Software and EdgeLab Module
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a security alert regarding the EdgeSuite software and EdgeLab module from In Log. Affected medical analysis laboratories have been notified directly by the company.
Product Recall: Artis PL E and Artis Symbiose Intraocular Lenses
The French National Agency for the Safety of Medicines and Health Products (ANSM) has announced a product recall for Artis PL E and Artis Symbiose intraocular lenses manufactured by Cristalens Industrie. This safety action, registered under number R2606056, requires healthcare facilities to take immediate action regarding the affected lots.
KY Board of Pharmacy Alert on Compounded GLP-1/GIP Drugs
The Kentucky Board of Pharmacy issued an alert regarding the compounding and dispensing of GLP-1/GIP drugs like semaglutide and tirzepatide from 503B outsourcing facilities. The alert clarifies when such compounding is permissible, referencing FDA guidance and court decisions concerning drug shortage lists and enforcement discretion.
KY Board Fines Med Save Pharmacy $5,000, Revokes Licenses
The Kentucky Board of Pharmacy has fined Med Save Pharmacy $5,000 and revoked its licenses following medication errors that led to the hospitalization of three pediatric patients. The pharmacy compounded misbranded and adulterated clonidine suspensions, violating multiple state statutes and regulations.
Kentucky Board of Pharmacy Suspends Wilson Family Pharmacy
The Kentucky Board of Pharmacy has issued an emergency suspension order for Wilson Family Pharmacy INC and pharmacist owner Jigna G Patel, effective August 15, 2025. The suspension follows preliminary findings of serious violations, including inadequate security of prescription drugs and dispensing medication without valid prescriptions, posing an imminent risk to public health.
Kentucky Pharmacy Technician Regulations Updated
The Kentucky Board of Pharmacy has updated regulations concerning pharmacy technicians, specifically 201 KAR 2:045 and 2:165. These amendments clarify technician roles, delegate new responsibilities to certified technicians, and centralize initial application requirements, including mandatory registration for an NABP e-profile.
DEA Extends Telemedicine Flexibilities for Controlled Medications
The DEA, in conjunction with HHS, has extended current telemedicine flexibilities for prescribing controlled medications through December 31, 2026. This allows DEA-registered practitioners to remotely prescribe Schedule II-V controlled medications, including certain narcotic medications for opioid use disorder treatment, without a prior in-person evaluation.
WV Board of Pharmacy Warns of Phone Scam Targeting Licensees
The West Virginia Board of Pharmacy has issued a warning regarding a phone scam targeting its licensees. Scammers are impersonating Board investigators, claiming disciplinary action and attempting to solicit payment over the phone. The Board reminds licensees that it will never request payment in lieu of an investigation.
WV Board of Pharmacy CSMP Modernization to RxGov System
The West Virginia Board of Pharmacy is modernizing its Controlled Substances Monitoring Program (CSMP) by transitioning from the CSAPP platform to the RxGov system. This upgrade aims to improve performance, data quality, and reporting capabilities. Key transition dates are outlined, with a full cutover expected in early March 2026.
WV Pharmacy Board Adopts CDC COVID-19 Vaccine Recommendations
The West Virginia Board of Pharmacy has adopted the CDC's recommendations for the 2025-2026 COVID-19 vaccines. This guidance allows pharmacists, technicians, and interns to administer vaccines to individuals aged 3 years and older, based on individual decision-making and CDC risk factor guidelines.
Louisiana Board of Pharmacy Office Closure due to Hurricane Ida
The Louisiana Board of Pharmacy announced an extension of its office closure due to Hurricane Ida, now through September 5, 2021. The office will remain closed to visitors due to staffing impacts from COVID-19, with materials to be deposited via mail slot or submitted electronically.
Louisiana Pharmacy Credential Renewal Notice
The Louisiana Board of Pharmacy has issued a notice regarding the credential renewal cycle for pharmacists and pharmacies. The renewal period for licenses and permits will be open from November 1 to December 31, 2021, with options for online or paper applications.
Louisiana Board of Pharmacy Office Closure Due to Hurricane Nicholas
The Louisiana Board of Pharmacy announced the closure of its state office on September 15, 2021, due to anticipated severe weather from Hurricane Nicholas. The office is expected to reopen for business, though not for visitors, on September 16, 2021, unless the closure order is extended.
Louisiana Board of Pharmacy Office Closure Due to COVID-19
The Louisiana Board of Pharmacy announced its office is closed to visitors effective immediately due to COVID-19 illness impacting staff levels. Licensees and applicants are directed to use mail or email for submissions and inquiries, as phone lines are on auto-attendant.
Louisiana Board of Pharmacy Office Reopens to Business, Remains Closed to Public
The Louisiana Board of Pharmacy has reopened its office for business following Hurricane Ida closures. However, due to insufficient staffing, the office remains closed to public visitors. Deliveries can be made via the mail slot, and inquiries should be directed to the general email address.
Florida MQA releases 2025-26 Q2 performance report
Florida MQA releases 2025-26 Q2 performance report
MEAC Medical Equipment Advisory Committee Meeting Announcement
The Mississippi Board of Pharmacy has announced a meeting for the Medical Equipment Advisory Committee (MEAC) on December 2, 2025. The meeting will cover topics related to medical equipment and is scheduled to take place at the Board's office in Jackson, Mississippi.
Mississippi Board of Pharmacy Final Rule Effective
The Mississippi Board of Pharmacy has filed a final administrative rule with the Secretary of State. This rule will become effective on March 13, 2026, impacting healthcare providers within the state.
MS Board of Pharmacy Resolution for State of Emergency Ice Storm
The Mississippi Board of Pharmacy has issued a resolution acknowledging the state of emergency due to an ice storm. This resolution outlines temporary measures and guidance for pharmacies to ensure continued patient access to medications during the emergency period.
MS Board of Pharmacy Accepting Applications for 2 Positions
The Mississippi Board of Pharmacy is seeking applications for two positions: a Compliance Agent and a Staff Attorney. The job posting for the Compliance Agent will remain open until February 4, 2026, and includes statewide field work. The Staff Attorney position requires at least five years of legal experience and familiarity with administrative law.
Contract Award for Pharmacy Professionals Recovery Services
The Mississippi Board of Pharmacy has announced a contract award for pharmacy professionals recovery services. This notice serves to inform stakeholders about the selection of a service provider to offer support and resources for pharmacy professionals facing substance abuse or other challenges.
Colorado Identifies Measles Case in Unvaccinated Adult
Colorado public health officials have identified a case of measles in an unvaccinated adult in Weld County. The individual had recent travel to an outbreak area and was hospitalized. The notice provides information on symptoms, prevention, and known exposure locations.
Virginia Adjudication Process Policy for Disciplinary Actions
The Virginia Department of Health Professions has revised its policy on the adjudication process for disciplinary actions against healthcare practitioners and organizations. This updated guidance, originally published in 1997 and revised in 2022, outlines the procedures for receiving reports, conducting investigations, and enforcing orders to protect public health.
Virginia Board of Nursing Sanctioning Reference Points Manual
The Virginia Board of Nursing has revised its Sanctioning Reference Points (SRP) Manual, last updated in July 2022. This guidance document provides a systematic analysis of sanctions for disciplinary cases involving health professionals regulated by the Board, including nurses, CNAs, RMAs, and LMTs.
Virginia Subpoena Request Instructions for Board of Nursing Proceedings
The Virginia Department of Health Professions has issued instructions for requesting subpoenas in proceedings before the Board of Nursing. The guidance outlines the written request process, required information for witness testimony and document production, and delivery requirements to the Assistant Attorney General.
Virginia DHP Enforcement Division FAQ on Disciplinary Proceedings
The Virginia Department of Health Professions (DHP) has published a Frequently Asked Questions (FAQ) document detailing its Health Professions Enforcement Division's processes. The FAQ clarifies who can file complaints, who can be complained about, how to file a complaint, and what happens to complaints, including disciplinary actions taken by the Health Regulatory Boards.
California DCA Enforcement Statistics and Performance Measures
The California Department of Consumer Affairs (DCA) has published updated enforcement statistics and performance measures for DCA licensees. These statistics track case volume, intake, investigation, formal discipline, and probation cycles, providing data for consumer protection efforts.
CA Board of Registered Nursing: Disclosure of Convictions and License Discipline
The California Board of Registered Nursing requires RNs to disclose any license discipline or criminal convictions sustained since their last renewal upon license renewal. This guidance details what constitutes a conviction, what types of license discipline must be reported, and the specific documentation required for disclosure.
CA Board of Registered Nursing Enforcement: Unlicensed Practice Citations
The California Board of Registered Nursing has cited 134 individuals for unlicensed nursing practice and impersonation. These citations, issued under Business and Professions Code Sections 2795 and 2796, carry fines and penalties for practicing without an active RN license.
CA Board of Registered Nursing: Disciplinary Actions and Legal Terms
The California Board of Registered Nursing (BRN) has published a webpage explaining its disciplinary actions and related legal terminology. The page details the process for viewing disciplinary documents, defines terms such as 'Accusation' and 'Gross Negligence,' and outlines the factors considered when determining disciplinary penalties for registered nurses.
CA Board of Registered Nursing Enforcement Press Releases
The California Board of Registered Nursing (BRN) has published a series of press releases detailing enforcement actions against individuals impersonating nurses or engaging in illegal practices. These releases highlight arrests for identity theft, illegal prescription issuance, and forging transcripts to obtain nursing credentials.
Iowa Board of Nursing Complaint and Investigation Process
The Iowa Board of Nursing has published guidance detailing its complaint and investigation process for nursing professionals. The document outlines who can make a complaint, the types of violations the board investigates, and how to submit a complaint, including tips for patients and employers.
Iowa Board of Nursing Public Access Portal
The Iowa Board of Nursing has launched a new online portal for public access to nursing license and disciplinary documents. The portal allows the general public to verify licenses and view disciplinary actions without logging in, while other entities can create accounts for additional services.
Iowa Board of Nursing Complaint Process and Discipline Documents
The Iowa Board of Nursing has published updated guidance on its complaint process, detailing who may make a complaint, how to submit one, and what types of issues are investigated. The document also provides tips for patients, employers, and law enforcement, and links to relevant forms and discipline documents.
Iowa nursing disciplinary actions involve complaint review, sanctions, and reinstatement
Iowa nursing disciplinary actions involve complaint review, sanctions, and reinstatement
Arkansas Nursing Board Disciplinary Actions - January 2026
The Arkansas State Board of Nursing has published its disciplinary actions for January 2026. The list includes various actions such as probation, letters of reprimand, suspension, voluntary surrender, and cease and desist orders against licensed nurses. Violations cited include professional misconduct and breaches of nursing standards.
Arkansas Nursing Board December 2025 disciplinary actions listed
Arkansas Nursing Board December 2025 disciplinary actions listed
NM Medical Board Actions: Fines, Suspensions, Revocations, Surrenders
The New Mexico Medical Board took various disciplinary actions against healthcare providers between January 1, 2024, and March 31, 2024. Actions included fines, license suspensions, revocations, and voluntary surrenders, often related to adverse actions in other states or failure to report such actions.
NM Medical Board Disciplinary Orders
The New Mexico Medical Board issued disciplinary orders and notices for multiple medical professionals between January 1, 2025, and March 31, 2025. Actions include notices of contemplated action, immediate suspensions, and orders of revocation based on alleged violations of the Medical Practice Act and related rules.
New Mexico Medical Board Disciplinary Actions
The New Mexico Medical Board has issued several disciplinary orders, including license revocations, denials, and stipulations for the second quarter of 2025. These actions address violations of the Medical Practice Act, Impaired Health Care Provider Act, and Uniform Licensing Act, impacting licensed medical professionals in the state.
New Mexico Medical Board Disciplinary Orders
The New Mexico Medical Board issued disciplinary orders between July 1, 2025, and September 30, 2025. Actions included stipulations for withdrawal of applications, notices of contemplated action for various violations, stipulated orders with reprimands and fines, and default orders of revocation.
NM Medical Board Actions - Stipulations, Suspensions, Reprimands
The New Mexico Medical Board issued several disciplinary actions in Q4 2025, including stipulations of licensure with conditions, voluntary suspensions, interim consent agreements, and reprimands. These actions were taken following investigations into alleged violations of the Medical Practice Act.
Georgia Medical Board Orders - February 2026
The Georgia Composite Medical Board issued 12 public orders in February 2026, including final decisions, public consent orders, voluntary surrenders, and orders of summary suspension for physicians and physician assistants. One order details a final decision against Carlos Cossio, Sr., MD, for patient communication issues and a stalking conviction.
Georgia Medical Board Public Orders
The Georgia Composite Medical Board issued four public orders in January 2026, including consent orders and a consent agreement for licensure. These orders impose probation and specific conditions on licensed physicians and a senior laser practitioner.
Georgia Medical Board Orders - February 2025
The Georgia Composite Medical Board issued two public orders in February 2025 concerning physician and physician assistant actions. These orders include a Public Consent Order for a physician and a Consent Agreement for Reinstatement for a physician assistant.
Pennsylvania Board of Medicine Professional Licensing and Actions
The Pennsylvania Board of Medicine provides information on professional licensing services, including applying for, renewing, and searching for licensed professionals via the PALS website. The document outlines the application process, including considerations for criminal history and the board's review and decision-making process for licensure.
Organic Moringa Recalled Due to Salmonella Contamination
The Rhode Island Department of Health announced a recall of Organic Moringa products due to potential Salmonella contamination. Consumers are advised not to consume the product and to discard it or return it for a refund.
Rabies vaccine recalled due to sterile water mix-up
The Rhode Island Department of Health announced a recall of a rabies vaccine due to a mix-up where sterile water was used instead of the vaccine. This recall affects healthcare providers and potentially patients who received the affected vaccine.
Navitas Organics chia seeds recalled for Salmonella contamination
The Rhode Island Department of Health announced a recall of Navitas Organics chia seeds due to potential Salmonella contamination. Consumers who purchased the affected product are advised not to consume it and to dispose of it or return it for a refund. This recall impacts food manufacturers, retailers, and importers.
Rhode Island Drug Overdose Data Update
The Rhode Island Department of Health has reported 55 non-fatal drug overdoses occurred in the state between March 10 and March 16. This data update provides situational awareness regarding the ongoing opioid crisis.
DEA Warns About Methamphetamine and Street Names
The DEA issued a public safety alert warning about methamphetamine, listing its various street names such as Crank, Crystal, and Ice. The alert directs readers to a DEA factsheet for more information on the drug and its effects.
DEA Public Safety Alert: Fentanyl Affects All Communities
The DEA issued a public safety alert via Twitter, emphasizing that fentanyl affects all communities regardless of race, age, or economic status. The alert, from DEA SAC D. Olesky, reiterates the DEA's goal of a fentanyl-free America and mentions a joint effort with Aurora Police to combat drug trafficking.
Iowa Safe Haven Law - 80 Infants Total
The Iowa Department of Health and Human Services announced that a baby girl was declared a safe haven in March, bringing the total to 80 infants since the law's inception. The notice reiterates the provisions of the Safe Haven Law and provides resources for prospective foster and adoptive parents.
DEA Notice: SpecGx LLC Importer Application for Controlled Substances
The DEA has issued a notice regarding an application from SpecGx LLC to be registered as an importer of Schedule II controlled substances, including Phenylacetone, Coca Leaves, Thebaine, Opium, Poppy Straw Concentrate, and Tapentadol. Interested parties can submit comments or objections by April 20, 2026.
DEA Notice: Patheon API Services Importer Registration Application
The DEA has published a notice regarding an application from Patheon API Services, Inc. for registration as an importer of specific controlled substances, including Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. Interested parties can submit comments or hearing requests by April 20, 2026.
DEA Notice of Application for Bulk Controlled Substance Manufacturer Registration
The DEA has published a notice regarding an application from Siegfried Grafton, Inc. to be registered as a bulk manufacturer of various controlled substances, including Schedule I and II drugs. Interested parties can submit comments or requests for a hearing by May 18, 2026.
DEA Bulk Manufacturer Application for Controlled Substances
The DEA has published a notice regarding an application from Sterling Wisconsin, LLC to be registered as a bulk manufacturer of Schedule I and II controlled substances, including Lysergic Acid Diethylamide, Marihuana Extract, and Oliceridine. Registered manufacturers and applicants can submit comments or hearing requests by May 18, 2026.
National Institute of Diabetes and Digestive and Kidney Diseases; Closed Meeting Notice
The National Institutes of Health (NIH) has published a notice regarding a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases. The meeting is scheduled for July 1, 2026. This notice serves as an informational announcement.
Center for Scientific Review; Notice of Closed Meetings
The National Institutes of Health (NIH) Center for Scientific Review has announced upcoming closed meetings. These meetings are scheduled for April 16, 2026, and involve discussions related to grant applications and review processes.
FDA Draft Guidance on New Approach Methodologies in Drug Development
The FDA has issued draft guidance for industry on the use of New Approach Methodologies (NAMs) in drug development. This guidance provides recommendations for sponsors on how to incorporate NAMs into their regulatory submissions. The comment period for this draft guidance closes on May 18, 2026.
FDA Proposed Collection of Information on Premarket Notifications
The FDA has proposed a new collection of information regarding premarket notifications. This is a request for comments on the proposed collection, with a deadline of May 18, 2026.
FDA Guidance on Pyrogen and Endotoxin Testing
The FDA has issued guidance for biological product, drug, and device firms regarding pyrogen and endotoxin testing. This document provides recommendations based on current FDA thinking concerning USP and AAMI standards for bacterial endotoxin and pyrogen tests.
Pennsylvania Delivers $6.6 Million for EMS Professionals
The Pennsylvania administration announced the delivery of $6.6 million to equip Emergency Medical Services (EMS) professionals across the Commonwealth. This funding, part of the 2025-26 budget, aims to recruit, train, and equip EMS personnel to improve response times and save lives.
WTC Health Program Denies Petition for Anti-GBM Glomerulonephritis
The Centers for Disease Control and Prevention (CDC) has issued a notice denying Petition 026 for the addition of Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis to the World Trade Center (WTC) Health Program. The agency found insufficient evidence to support its inclusion.
WA DOH Revokes and Suspends Health Care Provider Licenses
The Washington State Department of Health has revoked and suspended licenses for several health care providers in February 2026 due to professional misconduct, including sexual misconduct, financial exploitation, and substance abuse. These actions impact providers across multiple counties and highlight the department's ongoing enforcement of licensing standards.
Washington State DOH Disciplines Health Care Providers
The Washington State Department of Health has taken disciplinary actions against several health care providers in March 2026. Actions include probation, denial of applications, and intent to issue cease-and-desist orders due to criminal convictions, unlicensed practice, and unprofessional conduct.
Washington State Revokes, Suspends Health Care Provider Licenses
The Washington State Department of Health has revoked and suspended licenses and certifications for several health care providers. Actions include the indefinite suspension of a home care aide credential due to suspected theft and failure to respond to inquiries.
WA DOH Disciplinary Actions Against Health Care Providers
The Washington State Department of Health has taken disciplinary actions against several health care providers in March 2026. Actions include charges of unprofessional conduct, agreed orders to cease practice, and termination of probation. These actions address issues such as billing fraud, practicing without a credential, and inappropriate patient relationships.
FDA Document on Biochemical Changes in Red Blood Cells
The FDA has posted a document concerning biochemical changes in red blood cells. The document is available for review on Regs.gov, though specific details are restricted due to copyright.
FDA Radiology Devices Classification Regulatory Analysis
The FDA has published a regulatory analysis concerning the classification of radiology devices. This notice provides an overview of the agency's approach to classifying these medical devices, offering clarity to manufacturers and stakeholders.
FDA Guidance on EpCAM-Positive Cell Reduction by Filters
The FDA has issued guidance concerning the reduction of EpCAM-positive cells by filters. This document provides information relevant to drug manufacturers and medical device makers.
FDA PRIA Reference Data
The FDA has published reference data related to the Prescription Drug User Fee Act (PRIA) for May 2024. This notice includes national employment data relevant to PRIA submissions. It serves as an informational update for regulated entities.
FDA PRIA Reference SBA Size Standards Update
The FDA has posted an update regarding the Presolicitation Information and Analysis (PRIA) Reference, specifically concerning Small Business Administration (SBA) size standards. This notice updates the reference document used by the agency for certain regulatory processes.
FDA Guidance on Physicochemical Characterization of Topical Drug Products
The FDA has issued final guidance for industry on the physicochemical and structural characterization of topical drug products submitted in Abbreviated New Drug Applications (ANDAs). This guidance, which finalizes a draft from October 2022, provides recommendations to support bioequivalence demonstrations for generic topical products.
FDA Economic Analysis of CDRH Submission Requirements
The FDA has published an economic analysis concerning the submission requirements for the Center for Devices and Radiological Health (CDRH). This analysis provides insights into the economic impact of these requirements on medical device manufacturers.
FDA Medical Device User Fee Rates for FY 2024
The Food and Drug Administration (FDA) has posted the Medical Device User Fee rates for Fiscal Year 2024. This notice provides the updated fee schedule for medical device manufacturers.
Trauma Advisory Council Data and PI Subcommittee Meeting Announcement
The South Carolina Department of Public Health announced that the Trauma Advisory Council Data and PI Subcommittee will hold a virtual meeting on March 20, 2026. The agenda and meeting link are available on the event page.
Rabid Bat Confirmed in Aiken County, SC
The South Carolina Department of Public Health confirmed a rabid bat in Aiken County, with one dog exposed and quarantined. This is the second animal in Aiken County and the 18th statewide this year to test positive for rabies.
MDHHS Public Hearing on Weatherization Plan
The Michigan Department of Health and Human Services (MDHHS) is hosting a public hearing on its 2026 Weatherization Assistance Program State Plan. The plan covers July 1, 2026, to June 30, 2027, and includes updates to subgrantees, technical documents, and training plans.
Hometown Health Heroes Honored for Contributions to Michigan Residents
The Michigan Department of Health and Human Services (MDHHS) announced the 2026 Hometown Health Hero Award winners for their contributions to public health. Ten individuals and organizations were recognized for improving the health and well-being of Michigan residents.
Boil Water Advisory Rescinded for White Cloud, Kansas
The Kansas Department of Health and Environment (KDHE) has rescinded a boil water advisory for the City of White Cloud, Kansas. The advisory was initially issued due to a waterline break and loss of pressure, but laboratory testing has confirmed the water is now safe for consumption.
Tuttle Creek Cove Diesel Fuel Spill Advisory
The Kansas Department of Health and Environment (KDHE) has issued a stream advisory for Tuttle Creek Cove due to a diesel fuel spill from a commercial barge. The public is advised to avoid the cove until remediation efforts are complete and water contact is deemed safe.
Health Canada Recalls Vacuum Bag SU Large Due to Leakage Risk
Health Canada has issued a Type II recall for the Milestone S.R.L. Vacuum Bag SU Large due to a risk of leakage from the specimen container. Healthcare providers are advised to contact the manufacturer for additional information.
Angiographic Catheters Recalled Due to Molded Hub Non-Conformance
Health Canada has issued a recall for AngioDynamics' Soft-Vu and Accu-Vu 4 FR Angiographic Catheters due to a molded hub non-conformance. The defect may prevent guidewire passage, though no injuries have been reported in Canada. Healthcare providers should contact the manufacturer for information.
Hawaii DOH Reports Measles Virus in Kauaʻi Wastewater
The Hawaii Department of Health (DOH) reported detecting measles virus in a wastewater sample from Kauaʻi County, collected on February 25, 2026. This detection serves as an early indicator, prompting increased monitoring and awareness for potential measles cases statewide.